Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy Study of a Novel Cosmetic Product to Reduce an UVB Induced Erythema

NCT05300542 is registered in ClinicalTrials.gov with Amazentis SA as lead sponsor.

NCT NCT05300542
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05300542 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy Study of a Novel Cosmetic Product to Reduce an UVB Induced Erythema
Lead sponsor
Amazentis SA
Phase
Not applicable
Overall status
Completed
Start date
March 17, 2022
Completion date
April 13, 2022
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erythema, skin inflammation, sun damaged skin